Estimations des analystes de Wall Street pour Alector, Inc. (ALEC): objectif de cours de consensus, recommandations achat/conserver/vente et prévisions de revenus, BPA et EBITDA pour les prochains exercices.
Consensus des analystes
| Achat fort | 0 |
| Achat | 9 |
| Conserver | 3 |
| Vente | 2 |
| Vente forte | 0 |
| Analystes au total | 14 |
| Note moyenne (1-5) | 0.50 |
Surprises de Résultats Récentes
| Date | BPA Réel | BPA Estimé | vs Est. |
|---|---|---|---|
| 2026-11-05 | $-0.24 | ||
| 2026-08-06 | $-0.21 | $-0.23 | +8.1% |
| 2026-05-07 | $-0.21 | $-0.35 | +40.0% |
| 2026-02-25 | $-0.34 | $-0.39 | +12.8% |
| 2025-11-06 | $-0.34 | $-0.42 | +19.0% |
| 2025-08-07 | $-0.30 | $-0.45 | +33.3% |
| 2025-05-08 | $-0.41 | $-0.44 | +6.8% |
| 2025-02-26 | $-0.02 | $-0.61 | +96.7% |
Ratios de valorisation
| Prix / Valeur comptable | -18.68 |
| EV / EBITDA | -1.95 |
| Rendement du dividende | 0.00% |
Compte de Résultat (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenus | $416000 | $3.7M | $27.7M | $21.2M | $21.1M | $207.1M | $133.6M | $97.1M | $100.6M | $21.0M |
| Coût des Ventes | $13.7M | $29.9M | $73.0M | $100.5M | $156.9M | $189.4M | 0 | $8.8M | $185.9M | $9.7M |
| Marge Brute | -$13.3M | -$26.2M | -$45.4M | -$79.3M | -$135.8M | $17.7M | $133.6M | $88.2M | -$85.4M | $11.4M |
| R&D | $13.7M | $29.9M | $73.0M | $100.5M | $156.9M | $189.4M | $210.4M | $192.1M | $209.2M | $123.1M |
| Frais Généraux | $1.9M | $6.5M | $11.9M | $33.9M | $59.4M | $55.0M | $61.0M | $56.7M | $57.4M | $54.0M |
| Charges Opérationnelles | $15.5M | $36.4M | $85.0M | $35.1M | $59.4M | $55.0M | $271.5M | $240.0M | $59.6M | $157.2M |
| Résultat Opérationnel | -$15.1M | -$32.7M | -$57.3M | -$114.4M | -$195.2M | -$37.4M | -$137.8M | -$151.7M | -$145.0M | -$145.8M |
| EBITDA | -$14.9M | -$32.0M | -$56.3M | -$109.5M | -$187.9M | -$28.0M | -$121.6M | -$116.3M | -$110.1M | -$133.1M |
| Charges d'Intérêt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Résultat Avant Impôts | -$15.1M | -$32.5M | -$52.2M | -$105.4M | -$190.2M | -$36.3M | -$130.1M | -$125.2M | -$118.9M | -$142.8M |
| Impôts | 0 | 0 | 0 | 0 | 0 | 0 | $3.3M | $5.2M | $128000 | $168000 |
| Résultat Net | -$15.1M | -$32.5M | -$52.2M | -$105.4M | -$190.2M | -$36.3M | -$133.3M | -$130.4M | -$119.0M | -$142.9M |
| BPA | $-1.78 | $-0.63 | $-0.76 | $-1.62 | $-2.45 | $-0.45 | $-1.62 | $-1.56 | $-1.23 | $-1.39 |
| BPA Dilué | $-1.78 | $-0.63 | $-0.76 | $-1.62 | $-2.45 | $-0.45 | $-1.62 | $-1.56 | $-1.23 | $-1.39 |
| Actions en Circulation (Diluées) | $8.5M | $51.2M | $68.4M | $61.7M | $77.8M | $80.4M | $82.5M | $83.7M | $96.6M | $103.0M |
Prix
| Prix | $1.93 |
| Capitalisation | $214M |
| Bourse | NASDAQ |
| Pays | US |
Entreprises liées: ABOS · APLT · CRBP · FATE · IRD · MOLN · NKTX
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ALEC: Vue d'ensemble · Financiers · Valorisation · Statistiques · Technique · Actionnariat · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions